Skip to main content

Table 1 Demographics and clinical characteristics of HCV infected women enrolled in our study

From: HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects

Variable

Results (n = 24)

Italian nationality, n (%)

17 (70.8)

Age, mean ± SD

41 ± 9.5

PWIDs, n (%)

18 (75)

On OST, n (%)

13/18 (72.2)

Psychosis, n (%)

4 (16.6)

Alcohol abuse, n (%)

6 (25)

HBsAg, n (%)

1 (4.2)

HBcAb, n%

4 (16.6)

HIV, n (%)

6 (25)

Median (IQR) HCV RNA value

608,500 (339,575–1,449,312)

Genotypes, n (%)

1a

10 (41.6)

1b

1 (4.2)

2

3a

12 (50)

4

1 (4.2)

Fibrosis according to fibroscan® and FIB-4 value*, n (%)

Low

15 (62.5)

Intermediate

6 (25)

Advanced

3 (12.5)

  1. IQR interquartile range, PWIDs people who inject drugs, OST opioid substitution therapy, ART anti-retroviral therapy. *Low = METAVIR F0-F1 or FIB-4 < 1.45; Intermediate = METAVIR F2-F3 or FIB-4 between 1.45 and 3.25; Advanced = METAVIR F4 or FIB-4 > 3.25